[HTML][HTML] Expression of inducible factors reprograms CAR-T cells for enhanced function and safety
A Smole, A Benton, MA Poussin, MA Eiva… - Cancer Cell, 2022 - cell.com
Despite the success of CAR-T cell cancer immunotherapy, challenges in efficacy and safety
remain. Investigators have begun to enhance CAR-T cells with the expression of accessory …
remain. Investigators have begun to enhance CAR-T cells with the expression of accessory …
[HTML][HTML] Expression of Inducible Factors Reprograms CAR-T Cells for Enhanced Function and Safety
A Smole, A Benton, MA Poussin, MA Eiva… - Cancer cell, 2022 - ncbi.nlm.nih.gov
Despite the success of CAR-T cell cancer immunotherapy, challenges in efficacy and safety
remain. Investigators have begun to enhance CAR-T cells with expression of accessory …
remain. Investigators have begun to enhance CAR-T cells with expression of accessory …
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety
A Smole, A Benton, MA Poussin, MA Eiva… - Cancer Cell, 2022 - cell.com
Despite the success of CAR-T cell cancer immunotherapy, challenges in efficacy and safety
remain. Investigators have begun to enhance CAR-T cells with the expression of accessory …
remain. Investigators have begun to enhance CAR-T cells with the expression of accessory …
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety.
A Smole, A Benton, MA Poussin, MA Eiva… - Cancer Cell, 2022 - europepmc.org
Despite the success of CAR-T cell cancer immunotherapy, challenges in efficacy and safety
remain. Investigators have begun to enhance CAR-T cells with expression of accessory …
remain. Investigators have begun to enhance CAR-T cells with expression of accessory …
[HTML][HTML] Expression of inducible factors reprograms CAR-T cells for enhanced function and safety
A Smole, A Benton, MA Poussin, MA Eiva… - Cancer Cell, 2022 - Elsevier
Despite the success of CAR-T cell cancer immunotherapy, challenges in efficacy and safety
remain. Investigators have begun to enhance CAR-T cells with the expression of accessory …
remain. Investigators have begun to enhance CAR-T cells with the expression of accessory …
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety
A Smole, A Benton, MA Poussin, MA Eiva… - Cancer …, 2022 - pubmed.ncbi.nlm.nih.gov
Despite the success of CAR-T cell cancer immunotherapy, challenges in efficacy and safety
remain. Investigators have begun to enhance CAR-T cells with the expression of accessory …
remain. Investigators have begun to enhance CAR-T cells with the expression of accessory …
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety
A Smole, A Benton, MA Poussin, MA Eiva… - CANCER CELL, 2022 - iris.unisr.it
Despite the success of CAR-T cell cancer immunotherapy, challenges in efficacy and safety
remain. Investigators have begun to enhance CAR-T cells with the expression of accessory …
remain. Investigators have begun to enhance CAR-T cells with the expression of accessory …
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety
A Smole, A Benton, MA Poussin, MA Eiva… - paper.sciencenet.cn
Despite the success of CAR-T cell cancer immunotherapy, challenges in efficacy andsafety
remain. Investigators have begun to enhance CAR-T cells with the expressionof accessory …
remain. Investigators have begun to enhance CAR-T cells with the expressionof accessory …
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety.
A Smole, A Benton, MA Poussin, MA Eiva… - Cancer Cell, 2022 - europepmc.org
Despite the success of CAR-T cell cancer immunotherapy, challenges in efficacy and safety
remain. Investigators have begun to enhance CAR-T cells with the expression of accessory …
remain. Investigators have begun to enhance CAR-T cells with the expression of accessory …